|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
10,820,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
401,241 |
Avg
Vol: |
400,142 |
52
Week Range: |
$115.55 - $119.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s main product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
14,458 |
Total Buy Value |
$0 |
$0 |
$0 |
$851,078 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-03-09 |
4 |
S |
$97.87 |
$504,721 |
D/D |
(5,157) |
9,814 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-03-09 |
4 |
OE |
$7.36 |
$52,078 |
D/D |
5,157 |
11,061 |
|
- |
|
Wilson Kevin S. |
CEO and President |
|
2017-03-06 |
4 |
S |
$90.00 |
$720,000 |
I/I |
(8,000) |
6,432 |
|
- |
|
Eyl Steven M. |
EVP, Global Sales & Marketing |
|
2017-03-02 |
4 |
S |
$89.26 |
$892,554 |
D/D |
(10,000) |
11,271 |
|
- |
|
Eyl Steven M. |
EVP, Global Sales & Marketing |
|
2017-03-02 |
4 |
OE |
$7.36 |
$73,600 |
D/D |
10,000 |
21,271 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
41,202 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2017-02-23 |
4 |
D |
$81.00 |
$75,573 |
D/D |
(933) |
9,917 |
|
- |
|
Asakowicz Steve |
EVP, Comp. Animal Health Sales |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,850 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-02-23 |
4 |
D |
$81.00 |
$55,971 |
D/D |
(691) |
39,651 |
|
- |
|
Wisnewski Nancy |
EVP, Diag. Ops & Prod. Dev. |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,177 |
40,342 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-02-23 |
4 |
D |
$81.00 |
$63,018 |
D/D |
(778) |
117,927 |
|
- |
|
Mcginley Michael J |
Presi, Biologic. & Pharm. |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,452 |
118,705 |
|
- |
|
Eyl Steven M. |
EVP, Global Sales & Marketing |
|
2017-02-23 |
4 |
D |
$81.00 |
$64,557 |
D/D |
(797) |
11,271 |
|
- |
|
Eyl Steven M. |
EVP, Global Sales & Marketing |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
12,068 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-02-23 |
4 |
D |
$81.00 |
$75,654 |
D/D |
(934) |
9,814 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,748 |
|
- |
|
Napolitano Jason A |
COO, Chief Strategist and Sec. |
|
2017-01-10 |
4 |
AS |
$73.69 |
$373,635 |
D/D |
(5,000) |
38,702 |
|
- |
|
Gordon G Irwin |
Director |
|
2016-11-29 |
4 |
S |
$67.70 |
$4,739 |
D/D |
(70) |
14,876 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2016-11-28 |
4 |
S |
$65.50 |
$131,219 |
D/D |
(1,999) |
43 |
|
- |
|
Mcmahon John |
VP, Chief Financial Officer |
|
2016-11-28 |
4 |
OE |
$28.39 |
$73,329 |
D/D |
1,999 |
2,042 |
|
- |
|
Gordon G Irwin |
Director |
|
2016-11-28 |
4 |
S |
$65.26 |
$69,828 |
D/D |
(1,070) |
14,946 |
|
- |
|
Riley Sharon L. |
Director |
|
2016-11-25 |
4 |
B |
$66.87 |
$117,020 |
D/D |
1,750 |
1,750 |
2.39 |
- |
|
Gordon G Irwin |
Director |
|
2016-11-25 |
4 |
S |
$66.00 |
$123,764 |
D/D |
(1,860) |
16,016 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2016-11-22 |
4 |
S |
$64.85 |
$324,258 |
D/D |
(5,000) |
8,192 |
|
- |
|
Lippincott Rod |
EVP, Comp. Animal Health Sales |
|
2016-11-22 |
4 |
OE |
$7.36 |
$58,340 |
D/D |
5,000 |
13,192 |
|
- |
|
465 Records found
|
|
Page 13 of 19 |
|
|